Filing Flows › Idexx Laboratories (IDXX) › Q3 2026
Idexx Laboratories (IDXX) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 2, 2026
Idexx Laboratories (IDXX) reported revenue of $1.2B for the third quarter 2026 (Q3 2026), +10% from a year earlier and -0.2% from the quarter before. Operating margin was 33.1%, net earnings $317M (26.1% of revenue).
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2B | -0.2% | +10% |
| Gross profit | $764M | -2% | +12% |
| Operating profit | $402M | -5% | +13% |
| Net earnings | $317M | -6% | +15% |
| Operating cash flow | $450M | +30% | +12% |
| Free cash flow | $421M | +30% | +13% |
What changed
Revenue was $1.2B in Q3 2026, up 10% year over year and roughly flat from the previous quarter. Product revenue was the largest line at 60% of revenue. Product revenue added $0.07B year over year (up 10%), 61% of the total change.
Gross margin was 62.9%, up 1.1 points from Q3 2025. Operating profit was $0.40B, a 33.1% margin (up 1.0 points year over year). Of the extra revenue versus Q3 2025, 44% reached operating profit, above the 32% margin then. Operating expenses grew 10% against revenue growth of 10%. The fastest-growing cost line was General & admin (+16%). Net earnings were $0.32B, up 15% year over year. The effective tax rate was 20.6%.
Operating cash flow was $0.45B (up 12% year over year), 142% of net earnings. Non-cash charges added back $0.04B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.08B. Capital expenditures of $0.03B left free cash flow of $0.42B.
Questions
What was Idexx Laboratories' revenue in the third quarter 2026?
Idexx Laboratories (IDXX) reported revenue of $1.2B for the third quarter 2026 (Q3 2026), +10% from a year earlier and -0.2% from the quarter before.
Was Idexx Laboratories profitable in the third quarter 2026?
Operating profit was $402M (33.1% of revenue) and net earnings $317M.
Source: Idexx Laboratories 10-Q on SEC EDGAR.